Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ENDRA Life Sciences (NDRA) EBIAT (2016 - 2021)

Historic EBIAT for ENDRA Life Sciences (NDRA) over the last 6 years, with Q4 2021 value amounting to -$3.1 million.

  • ENDRA Life Sciences' EBIAT fell 3793.68% to -$3.1 million in Q4 2021 from the same period last year, while for Dec 2021 it was -$11.2 million, marking a year-over-year increase of 421.52%. This contributed to the annual value of -$11.5 million for FY2024, which is 1439.03% down from last year.
  • Per ENDRA Life Sciences' latest filing, its EBIAT stood at -$3.1 million for Q4 2021, which was down 3793.68% from -$2.7 million recorded in Q3 2021.
  • In the past 5 years, ENDRA Life Sciences' EBIAT ranged from a high of -$741623.0 in Q1 2017 and a low of -$4.8 million during Q4 2019
  • Moreover, its 5-year median value for EBIAT was -$2.7 million (2019), whereas its average is -$2.6 million.
  • Its EBIAT has fluctuated over the past 5 years, first plummeted by 28096.22% in 2018, then skyrocketed by 5319.98% in 2020.
  • Over the past 5 years, ENDRA Life Sciences' EBIAT (Quarter) stood at -$2.3 million in 2017, then fell by 3.09% to -$2.4 million in 2018, then tumbled by 103.3% to -$4.8 million in 2019, then skyrocketed by 53.2% to -$2.3 million in 2020, then plummeted by 37.94% to -$3.1 million in 2021.
  • Its EBIAT stands at -$3.1 million for Q4 2021, versus -$2.7 million for Q3 2021 and -$3.2 million for Q2 2021.